Professor Bernhard Küster, keynote speaker at EACR 2026, talks about his scientific journey from chemistry to chemical proteomics and precision medicine. He reflects on how an interdisciplinary mindset - combining chemistry, biology, and computational science - has shaped his approach to understanding how drugs act on proteins and how this knowledge can inform personalised cancer treatments. He also shares practical advice for early-career researchers on how to embrace interdisciplinarity in their work.

Bernhard discusses his team’s pioneering work developing technologies such as Prosit, Decrypt-E and Decrypt-M, and highlights how artificial intelligence is accelerating discoveries in proteomics. He also underscores the vital role of the clinical community in providing well-annotated tumour samples - an essential foundation for meaningful AI-driven cancer research.

🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast 

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The European Association for Cancer Research (EACR). Innehållet i podden är skapat av The European Association for Cancer Research (EACR) och inte av, eller tillsammans med, Poddtoppen.